GlassScriptPhysician profile
Mark W Lutz
NPI 1235141748
$1,124.05
in general payments reported to CMS, 2019-2025
12 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2023: $109 · 2024: $219 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $999.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $363.38 | 2023-2025 | General - Therapies, Watchman Flx, Watchman Access System |
| Novo Nordisk INC | $337.52 | 2025 | Wegovy |
| Janssen Pharmaceuticals, INC | $125.00 | 2021 | |
| Medtronic, INC. | $57.64 | 2024 | Micra, Selectsecure |
| Astrazeneca Pharmaceuticals LP | $54.56 | 2024 | Farxiga |
| Abbott Laboratories | $48.30 | 2025 | Perclose Prostyle, Mitraclip |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.40 | 2025 | Lifevest |
| Amgen INC. | $25.97 | 2025 | |
| Bridgebio Pharma, INC. | $20.81 | 2025 | Attruby |
| Kiniksa Pharmaceuticals International, Plc | $19.74 | 2024 | Arcalyst |
| Philips North America LLC | $19.07 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Novartis Pharmaceuticals Corporation | $16.66 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Lutz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.